Examkin

Question

Difficulty: EasyGeneral Internal Medicine

A physician is evaluating a hospitalized patient with chronic kidney disease who has developed anuria and profound muscle weakness over the past twelve hours. An electrocardiogram demonstrates prolonged PR intervals, widened QRS complexes, and tall, peaked T waves. A point-of-care basic metabolic panel reveals a serum potassium level of 7.47.4 mEq/L. Arrange the following therapeutic interventions in the most appropriate chronological order of administration for this patient's acute management.

  1. 1Intravenous calcium gluconate
  2. 2Intravenous regular insulin and dextrose
  3. 3Oral sodium zirconium cyclosilicate

Answer

The correct sequence is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin and dextrose, 3) Oral sodium zirconium cyclosilicate.
The fundamental treatment algorithm for severe hyperkalemia with electrocardiographic changes prioritizes immediate survival over actual potassium removal. Intravenous calcium gluconate works within 1 to 3 minutes to stabilize the resting membrane potential of cardiac myocytes, making it the mandatory first step. Next, intravenous regular insulin with dextrose acts within 15 to 30 minutes to push potassium inside the cells, providing a rapid but temporary drop in serum potassium. Finally, because the total body potassium remains elevated, a definitive removal method such as oral sodium zirconium cyclosilicate (a gastrointestinal potassium binder) is given, though its slow onset of action (hours) makes it inappropriate for acute cardiac stabilization.

Step-by-Step Solution

1
Identify the primary immediate threat to the patient's life.
The patient has severe hyperkalemia (7.47.4 mEq/L) with significant electrocardiogram changes, placing the patient at imminent risk of ventricular fibrillation or asystole.
Recognizing the acute cardiac risk dictates that the very first intervention must directly protect the heart.
2
Select the agent for cardiac membrane stabilization.
Intravenous calcium gluconate is identified as the first-line therapy.
Calcium directly antagonizes the membrane actions of potassium without actually lowering the serum potassium level, acting within minutes to stabilize the myocardium.
3
Select the agent for rapid intracellular shifting of potassium.
Intravenous regular insulin (with dextrose to prevent hypoglycemia) is chosen next.
Once the heart is protected, potassium must be rapidly cleared from the serum. Insulin drives potassium into cells, temporarily lowering serum levels within 15 to 30 minutes.
4
Select the agent for definitive total-body potassium elimination.
Oral sodium zirconium cyclosilicate (a gastrointestinal cation exchanger) is scheduled last.
Shifting agents only hide potassium inside cells. A binder or dialytic therapy is required to permanently excrete the potassium, but this process takes hours to work.

Key Concept

The algorithmic management of acute, severe hyperkalemia with electrocardiographic changes always follows a strict three-step chronological sequence: cardiac membrane stabilization (calcium), intracellular shifting (insulin/dextrose, albuterol), and definitive total-body elimination (gastrointestinal binders, diuretics, or dialysis).
Estimated Time:45s
Rate this question

Topics

General Internal Medicine

More questions from this topic